No Data
Express News | Abbvie's Deal for for Biotech Apogee Therapeutics Is Expected to Be Announced as Soon as Monday -FT
Express News | Under the Terms of the Deal Being Discussed, Abbvie Would Pay Apogee Shareholders $10.9Bn in Cash - FT
Express News | Abbvie Closes in on Nearly $11Bn Deal for Biotech Apogee Therapeutics - FT
AbbVie To Go Ex-Dividend On July 15th, 2026 With 1.73 USD Dividend Per Share
FDA Seeks Updated Labeling for Testosterone Therapies
AbbVie Keeps Quarterly Dividend at $1.73 a Share, Payable Aug. 14 to Holders of Record July 15
LoneBone : i dont think this article chose ABBV correctly. They brew drugs not beverages.
🫤